DoD Breast Cancer Breakthrough Award Level 3
The summary for the DoD Breast Cancer Breakthrough Award Level 3 grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept. of the Army -- USAMRAA, which is the U.S. government agency offering this grant.
DoD Breast Cancer Breakthrough Award Level 3: Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact. The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Level 3.Distinctive Features:· For this funding mechanism, small-scale clinical trials are allowed but not required. Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.· The research team must include two or more breast cancer consumer advocates.· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn.
Federal Grant Title: | DoD Breast Cancer Breakthrough Award Level 3 |
Federal Agency Name: | Dept. of the Army -- USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology and other Research and Development |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | HT942525BCRPBTA3 |
Type of Funding: | Grant |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | September 10th, 2025 |
Original Application Deadline: | September 10th, 2025 |
Posted Date: | April 22nd, 2025 |
Creation Date: | April 22nd, 2025 |
Archive Date: | October 10th, 2025 |
Total Program Funding: | $27,900,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 3 |
Cost Sharing or Matching: | No |
Last Updated: | April 22nd, 2025 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DoD Melanoma, Melanoma Academy Scholar Award
- • DoD Melanoma, Melanoma Academy Leadership Award
- • DoD Melanoma, Focused Program Award - Rare Melanomas
- • DoD Melanoma, Idea Award
- • DoD Melanoma, Survivorship Research Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept. of the Army -- USAMRAA
- • DoD Melanoma, Melanoma Academy Scholar Award
- • DoD Melanoma, Melanoma Academy Leadership Award
- • DoD Melanoma, Focused Program Award - Rare Melanomas